On the contrary, we characterized LITAF as a transcription factor in B-cell lymphoma, translocating to the nucleus and repressing BCL6 mRNA expression by binding to its regulatory region (Figure 2C-2G and Figure 3A). This evidence concerns the gene LITAF and B-cell non-Hodgkin lymphoma.